Clinical evaluation of rapid point-of-care antigen tests for diagnosis of SARS-CoV-2 infection
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-4373
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical evaluation of rapid point-of-care antigen tests for diagnosis of SARS-CoV-2 infection ; volume:40 ; number:9 ; day:22 ; month:5 ; year:2021 ; pages:1975-1981 ; date:9.2021
European journal of clinical microbiology & infectious diseases ; 40, Heft 9 (22.5.2021), 1975-1981, 9.2021
- Urheber
-
Koeleman, Johannes G. M.
Brand, Henk
Man, Stijn J. de
Ong, David S. Y.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10096-021-04274-7
- URN
-
urn:nbn:de:101:1-2021103020475427558606
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Koeleman, Johannes G. M.
- Brand, Henk
- Man, Stijn J. de
- Ong, David S. Y.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Rapid comparative evaluation of SARS-CoV-2 rapid point-of-care antigen tests
Performance of a Point-of-Care Test for the Rapid Detection of SARS-CoV-2 Antigen
Amplified parallel antigen rapid test for point-of-care salivary detection of SARS-CoV-2 with improved sensitivity
Correction to: Amplified parallel antigen rapid test for point-of-care salivary detection of SARS-CoV-2 with improved sensitivity
Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals
Safety considerations for the use of Point-Of-Care diagnostics during SARS-CoV-2 pandemic
Pooled analysis of laboratory-based SARS-CoV-2 antigen immunoassays
Comparing the diagnostic accuracy of point-of-care lateral flow antigen testing for SARS-CoV-2 with RT-PCR in primary care (REAP-2)
Determining half-life of SARS-CoV-2 antigen in respiratory secretion
Impaired detection of omicron by SARS-CoV-2 rapid antigen tests
Clinical assessment of the Roche SARS-CoV-2 rapid antigen test
Rapid comparative evaluation of SARS-CoV-2 rapid point-of-care antigen tests
Performance of a Point-of-Care Test for the Rapid Detection of SARS-CoV-2 Antigen
Amplified parallel antigen rapid test for point-of-care salivary detection of SARS-CoV-2 with improved sensitivity
Correction to: Amplified parallel antigen rapid test for point-of-care salivary detection of SARS-CoV-2 with improved sensitivity
Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals
Safety considerations for the use of Point-Of-Care diagnostics during SARS-CoV-2 pandemic
Pooled analysis of laboratory-based SARS-CoV-2 antigen immunoassays
Comparing the diagnostic accuracy of point-of-care lateral flow antigen testing for SARS-CoV-2 with RT-PCR in primary care (REAP-2)
Determining half-life of SARS-CoV-2 antigen in respiratory secretion
Impaired detection of omicron by SARS-CoV-2 rapid antigen tests
Clinical assessment of the Roche SARS-CoV-2 rapid antigen test
Rapid comparative evaluation of SARS-CoV-2 rapid point-of-care antigen tests
Performance of a Point-of-Care Test for the Rapid Detection of SARS-CoV-2 Antigen
Amplified parallel antigen rapid test for point-of-care salivary detection of SARS-CoV-2 with improved sensitivity
Correction to: Amplified parallel antigen rapid test for point-of-care salivary detection of SARS-CoV-2 with improved sensitivity
Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals
Safety considerations for the use of Point-Of-Care diagnostics during SARS-CoV-2 pandemic
Pooled analysis of laboratory-based SARS-CoV-2 antigen immunoassays
Comparing the diagnostic accuracy of point-of-care lateral flow antigen testing for SARS-CoV-2 with RT-PCR in primary care (REAP-2)
Determining half-life of SARS-CoV-2 antigen in respiratory secretion
Impaired detection of omicron by SARS-CoV-2 rapid antigen tests